Commonwealth Equity Services, Inc - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 166 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
Commonwealth Equity Services, Inc ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2017$1,109,000
-22.0%
63,846
-42.4%
0.01%
-22.2%
Q2 2017$1,421,000
+372.1%
110,871
+377.0%
0.01%
+350.0%
Q1 2017$301,000
+36.2%
23,245
+4.0%
0.00%0.0%
Q4 2016$221,000
+44.4%
22,345
+76.2%
0.00%
+100.0%
Q3 2016$153,000
+40.4%
12,6800.0%0.00%0.0%
Q2 2016$109,000
-55.0%
12,680
+18.5%
0.00%
-50.0%
Q2 2015$242,000
+82.0%
10,700
+1.9%
0.00%0.0%
Q1 2014$133,000
-73.5%
10,500
-68.7%
0.00%
-71.4%
Q4 2013$502,000
-10.2%
33,500
-33.8%
0.01%
-22.2%
Q3 2013$559,000
+43.3%
50,600
+3.1%
0.01%
+28.6%
Q2 2013$390,00049,1000.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders